A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab

Despite the unprecedented advances in the treatment of melanoma with immunotherapy, there continues to be a major need for biomarkers of clinical benefits and immune resistance associated with immune checkpoint inhibitors; microRNA could play a vital role in these efforts. This study planned to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobeissi, Iyad, Eljilany, Islam, Achkar, Tala, LaFramboise, William A., Santana-Santos, Lucas, Tarhini, Ahmad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179521/
https://www.ncbi.nlm.nih.gov/pubmed/37175874
http://dx.doi.org/10.3390/ijms24098167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179521/
https://www.ncbi.nlm.nih.gov/pubmed/37175874
http://dx.doi.org/10.3390/ijms24098167

Ejemplares similares